Download CCG & Trust Reports

Sign-in for access to your CCG's reports

Current planned work programme  

(The programme is subject to revisions from the Keele Oversight Group and may be altered according to the availability of specialist contributors.)

May 2017:

  • Class review of newer oral anticoagulants (NOACs) for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation

.

July 2017:

  • Pitolisant for the treatment of narcolepsy
  • Guanfacine for the treatment of ADHD

.

September 2017:

  • Class review of fixed-dose combination products in type 2 diabetes